References
- Agardan NB, Degim Z, Yilmaz S, et al. (2015). The effectiveness of raloxifene-loaded liposomes and cochleates in breast cancer therapy. AAPS PharmSciTech. [Epub ahead of print]. doi:10.1208/s12249-015-0429-3
- Ai X, Sun J, Zhong L, et al. (2014). Star-shape redox-responsive PEG-sheddable copolymer of disulfide-linked polyethylene glycol-lysine-di-tocopherol succinate for tumor-triggering intracellular doxorubicin rapid release: head-to-head comparison. Macromol Biosci 14:1415–28
- Chen H, Wu J, Sun M, et al. (2012). N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin. J Liposome Res 22:100–9
- Chu KS, Finniss MC, Schorzman AN, et al. (2014). Particle replication in nonwetting templates nanoparticles with tumor selective alkyl silyl ether docetaxel prodrug reduces toxicity. Nano Lett 14:1472–6
- Duan X, Xiao J, Yin Q, et al. (2013). Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram. ACS Nano 7:5858–69
- Etrych T, Šírová M, Starovoytova L, et al. (2010). DTX-HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release. Mol Pharm 7:1015–26
- Fry DW, White C, Goldman ID. (1978). Rapid separation of low molecular weight solutes from liposomes without dilution. Anal Biochem 90:809–15
- Ganesh T. (2007). Improved biochemical strategies for targeted delivery of taxoids. Bioorg Med Chem 15:3597–623
- He X, Li L, Su H, et al. (2015). Poly(ethylene glycol)-block-poly(ɛ-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery. Int J Nanomedicine 10:1791–804
- Jain JP, Jatana M, Chakrabarti A, et al. (2010). Amphotericin-B-loaded polymersomes formulation (PAMBO) based on (PEG)3-PLA copolymers: an in vivo evaluation in a murine model. Mol Pharm 8:204–12
- Kim H, Lee Y, Lee IH, et al. (2014). Synthesis and therapeutic evaluation of an aptide-docetaxel conjugate targeting tumor-associated fibronectin. J Control Release 178:118–24
- Letchford K, Burt HM. (2012). Copolymer micelles and nanospheres with different in vitro stability demonstrate similar paclitaxel pharmacokinetics. Mol Pharm 9:248–60
- Li XT, He ML, Zhou ZY, et al. (2015). The antitumor activity of PNA modified vinblastine cationic liposomes on Lewis lung tumor cells: in vitro and in vivo evaluation. Int J Pharm 487:223–33
- Liu D, Wang L, Liu Z, et al. (2010). Preparation, characterization, and in vitro evaluation of docetaxel-loaded poly(lactic acid)-poly(ethylene glycol) nanoparticles for parenteral drug delivery. J Biomed Nanotechnol 6:675–82
- Marzban E, Alavizadeh SH, Ghiadi M, et al. (2015). Optimizing the therapeutic efficacy of cisplatin PEGylated liposomes via incorporation of different DPPG ratios: in vitro and in vivo studies. Colloids Surf B Biointerfaces 136:885–91
- Park MH, Keum CG, Song JY, et al. (2014). A novel aqueous parenteral formulation of docetaxel using prodrugs. Int J Pharm 462:1–7
- Peng PC, Hong RL, Tsai YJ, et al. (2015). Dual-effect liposomes encapsulated with doxorubicin and chlorin e6 augment the therapeutic effect of tumor treatment. Lasers Surg Med 47:77–87
- Wang D, Fu Q, Tang J, et al. (2015a). Molecular-matched materials for anticancer drug delivery and imaging. Nanomedicine (Lond) 10:3003–13
- Wang J, Li L, Du Y, et al. (2015b). Improved oral absorption of doxorubicin by amphiphilic copolymer of lysine-linked ditocopherol polyethylene glycol 2000 succinate: in vitro characterization and in vivo evaluation. Mol Pharm 12:463–73
- Wang J, Sun J, Chen Q, et al. (2012). Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance. Biomaterials 33:6877–88
- Wang Y, Liu D, Zheng Q, et al. (2014). Disulfide bond bridge insertion turns hydrophobic anticancer prodrugs into self-assembled nanomedicines. Nano Lett 14:5577–83
- Wohl AR, Michel AR, Kalscheuer S, et al. (2014). Silicate esters of paclitaxel and docetaxel: synthesis, hydrophobicity, hydrolytic stability, cytotoxicity, and prodrug potential. J Med Chem 57:2368–79
- Zhigaltsev IV, Winters G, Srinivasulu M, et al. (2010). Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles. J Control Release 144:332–40